Acuña, Bernadeth .
HRN: 27-04-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2025
CEFTRIAXONE 1G (VIAL)
04/28/2025
05/05/2025
IV
2g
OD
T/C Hyperglycemic Crisis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes